Although further studies are needed to elucidate the molecular relationship between TRIM25 and PPARγ in tumor progression, our results extend our knowledge regarding the regulation of PPARγ and potential targets for the development of novel therapeutic approaches targeting obesity and metabolic diseases. The gene discussed is PPARG; the disease is obesity due to melanocortin 4 receptor deficiency.